Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06835816

Amino Acid Supplementation in Continuous Renal Replacement Therapy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Karolinska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

ICU patients treated with continuous renal replacement therapy is recruited prior to start of treatment. Blood samples are drawn and then dialysis start without amino acid supplementation. After a few hours samples are drawn from blood and dialysate. Then patients are given amino acid supplementation (33.5g/24hrs) for 20-24 hours. New samples are drawn and amino acid supplementation is increased to 67g/24hrs and new samples are drawn after additional 24 hours. Then CRRT will continue with the full amino acid supplementation (standars of care).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAmino acid supplementation (Glavamin, Fresenius Kabi)Mixture of amino acids (67 g / 500 ml) given intravenously

Timeline

Start date
2025-02-03
Primary completion
2026-12-31
Completion
2028-12-31
First posted
2025-02-19
Last updated
2025-02-19

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06835816. Inclusion in this directory is not an endorsement.